10x Genomics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $7.41 billion, with shareholders equity totaling $838.04 million.
The company employs approximately 290 people and operates in the Health sector, within the Life Science Tools and Services industry.
Over the past 12 months, 10x Genomics Inc. reported $618.58 million in revenue, generating net income of $-67.08 million.
Key financial metrics include a P/E ratio of -110.41, a price-to-book (P/B) ratio of 8.84, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker TXG.